Genotypos
Private Company
Funding information not available
Overview
Genotypos is a European genetic diagnostics company that has rapidly established itself as a key service provider, leveraging over 20 years of collective market experience from its founding team. The company offers a broad catalog of tests analyzing over 20,000 genes, serving more than 200 cooperating hospitals. Its business model is centered on providing accredited laboratory services directly to healthcare providers and patients, positioning it in the growing personalized medicine market. While privately held and revenue-generating, it faces competition from larger international labs and depends on regional healthcare reimbursement policies.
Technology Platform
Integrated, accredited clinical laboratory offering a full suite of genetic testing technologies including molecular diagnostics, cytogenetics, genomics, cytogenomics, and flow cytometry. Capable of analyzing over 20,000 genes, focusing on translating established technologies into clinically actionable diagnostic services.
Opportunities
Risk Factors
Competitive Landscape
Genotypos competes in the fragmented genetic diagnostics market against large multinational laboratory corporations (e.g., Quest Diagnostics, Eurofins) and other regional specialty labs. Its competitive edge lies in its deep local integration, broad accredited test menu, and scientific expertise tailored to the Greek healthcare context. It must compete on quality, service, and cost.